Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    November 2018
  1. OH TJ, Moon JH, Choi SH, Lim S, et al
    Body-weight fluctuation and incident diabetes mellitus, cardiovascular disease, and mortality: a 16-year prospective cohort study.
    J Clin Endocrinol Metab. 2018 Nov 29. pii: 5214055. doi: 10.1210/jc.2018-01239.
    PubMed     Text format     Abstract available


  2. GUASCH-FERRE M, Ruiz-Canela M, Li J, Zheng Y, et al
    Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk.
    J Clin Endocrinol Metab. 2018 Nov 13. pii: 5172268. doi: 10.1210/jc.2018-01000.
    PubMed     Text format     Abstract available


    September 2018
  3. TAMHANE S, Rodriguez-Gutierrez R, Iqbal AM, Prokop L, et al
    Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2018 Sep 28. pii: 5107761. doi: 10.1210/jc.2018-01862.
    PubMed     Text format     Abstract available


  4. RITCHEY ME, Harding A, Hunter S, Peterson C, et al
    Cardiovascular Safety During and After Use of Phentermine and Topiramate.
    J Clin Endocrinol Metab. 2018 Sep 21. pii: 5104461. doi: 10.1210/jc.2018-01010.
    PubMed     Text format     Abstract available


    August 2018
  5. STRAND E, Rebnord EW, Pedersen ER
    Response to letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073239. doi: 10.1210/jc.2018-01647.
    PubMed     Text format    


  6. LIEPINSH E, Dambrova M
    Letter to the Editor: Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Aug 14. pii: 5073236. doi: 10.1210/jc.2018-01408.
    PubMed     Text format    


  7. HSU PF, Sung SH, Cheng HM, Shin SJ, et al
    Cardiovascular benefits of acarbose versus sulfonylureas in type 2 diabetic patients treated with metformin.
    J Clin Endocrinol Metab. 2018 Aug 2. pii: 5063484. doi: 10.1210/jc.2018-00040.
    PubMed     Text format     Abstract available


    July 2018
  8. LYU Y, Luo Y, Li C, Guo X, et al
    Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China.
    J Clin Endocrinol Metab. 2018 Jul 3. pii: 5047769. doi: 10.1210/jc.2018-00422.
    PubMed     Text format     Abstract available


    May 2018
  9. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005949. doi: 10.1210/jc.2018-00470.
    PubMed     Text format     Abstract available


  10. PARK J, Blackburn BE, Ganz PA, Rowe K, et al
    Risk Factors for Cardiovascular Disease among Thyroid Cancer Survivors: Findings from the Utah Cancer Survivors Study.
    J Clin Endocrinol Metab. 2018 May 29. pii: 5005948. doi: 10.1210/jc.2017-02629.
    PubMed     Text format     Abstract available


  11. THURSTON RC, Bhasin S, Chang Y, Barinas Mitchell E, et al
    Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
    J Clin Endocrinol Metab. 2018 May 18. pii: 4999000. doi: 10.1210/jc.2018-00579.
    PubMed     Text format     Abstract available


  12. OTTOSSON F, Smith E, Melander O, Fernandez C, et al
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed     Text format     Abstract available


    April 2018
  13. STAHLI BE, Nozza A, Schrieks IC, Buse JB, et al
    Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.
    J Clin Endocrinol Metab. 2018 Apr 6. pii: 4963641. doi: 10.1210/jc.2017-02772.
    PubMed     Text format     Abstract available


    March 2018
  14. FAWAD A, Bergmann A, Struck J, Nilsson PM, et al
    Proneurotensin predicts cardiovascular disease in an elderly population.
    J Clin Endocrinol Metab. 2018 Mar 13. pii: 4931667. doi: 10.1210/jc.2017-02424.
    PubMed     Text format     Abstract available


  15. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Response to Letter: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931069. doi: 10.1210/jc.2018-00244.
    PubMed     Text format    


  16. PASCHOU SA, Anagnostis P, Goulis DG, Siasos G, et al
    Letter to the Editor: Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2018 Mar 12. pii: 4931067. doi: 10.1210/jc.2018-00018.
    PubMed     Text format    


    February 2018
  17. MEUN C, Franco OH, Dhana K, Jaspers L, et al
    High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study.
    J Clin Endocrinol Metab. 2018 Feb 1. pii: 4834041. doi: 10.1210/jc.2017-02421.
    PubMed     Text format     Abstract available


    January 2018
  18. WU CJ, Kao TW, Chang YW, Peng TC, et al
    Does the additional component of calf-circumference refine metabolic syndrome in Correlating with Cardiovascular Risk?
    J Clin Endocrinol Metab. 2018 Jan 15. pii: 4802111. doi: 10.1210/jc.2017-02320.
    PubMed     Text format     Abstract available


  19. DEGERUD E, Nygard O, de Vogel S, Hoff R, et al
    Plasma 25-hydroxyvitamin D and mortality in patients with suspected stable angina pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794886. doi: 10.1210/jc.2017-02328.
    PubMed     Text format     Abstract available


  20. STRAND E, Rebnord EW, Flygel MR, Lysne V, et al
    Serum Carnitine Metabolites and Incident Type 2 Diabetes Mellitus in Patients with Suspected Stable Angina Pectoris.
    J Clin Endocrinol Metab. 2018 Jan 9. pii: 4794884. doi: 10.1210/jc.2017-02139.
    PubMed     Text format     Abstract available


  21. YU D, Cai Y, Graffy J, Holman D, et al
    Development and external validation of risk scores for cardiovascular hospitalisation and rehospitalisation in diabetes patients.
    J Clin Endocrinol Metab. 2018 Jan 8. pii: 4792932. doi: 10.1210/jc.2017-02293.
    PubMed     Text format     Abstract available


    December 2017
  22. KIM C, Aroda VR, Goldberg RB, Younes N, et al
    Androgens, irregular menses, and risk of diabetes and coronary artery calcification in the Diabetes Prevention Program.
    J Clin Endocrinol Metab. 2017 Dec 6. pii: 4693937. doi: 10.1210/jc.2017-01829.
    PubMed     Text format     Abstract available


    October 2017
  23. TROISI R, Titus L, Hatch EE, Palmer JR, et al
    A Prospective Cohort Study of Prenatal Diethylstilbestrol Exposure and Cardiovascular Disease Risk.
    J Clin Endocrinol Metab. 2017 Oct 20. doi: 10.1210/jc.2017-01940.
    PubMed     Text format     Abstract available


  24. ANEKE-NASH CS, Xue X, Qi Q, Biggs ML, et al
    The Association between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.
    J Clin Endocrinol Metab. 2017 Oct 12. doi: 10.1210/jc.2017-01273.
    PubMed     Text format     Abstract available


    September 2017
  25. RHEE EJ, Cho JH, Kwon H, Park SE, et al
    Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study.
    J Clin Endocrinol Metab. 2017 Sep 27. doi: 10.1210/jc.2017-01723.
    PubMed     Text format     Abstract available


  26. PLAT J, Vreugdenhil ACE
    Response to Letter: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01894.
    PubMed     Text format    


  27. RADETTI G, Longhi S, Sartorio A, Grugni G, et al
    Letter to the Editor: Association of TSH With Cardiovascular Disease Risk in Overweight and Obese Children During Lifestyle Intervention.
    J Clin Endocrinol Metab. 2017 Sep 18. doi: 10.1210/jc.2017-01505.
    PubMed     Text format    


  28. BERGTHORSDOTTIR R, Ragnarsson O, Skrtic S, Glad CAM, et al
    Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients with Addison's Disease; a case-control study.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01324.
    PubMed     Text format     Abstract available


  29. MARAKA S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, et al
    Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2017 Sep 13. doi: 10.1210/jc.2017-01643.
    PubMed     Text format     Abstract available


  30. KANG YM, Cho YK, Lee SE, Park JY, et al
    Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study.
    J Clin Endocrinol Metab. 2017;102:3443-3451.
    PubMed     Text format     Abstract available


    August 2017
  31. MONGRAW-CHAFFIN ML, Allison MA, Burke GL, Criqui MH, et al
    CT derived body fat distribution and incident cardiovascular disease: The Multi-Ethnic Study of Atherosclerosis.
    J Clin Endocrinol Metab. 2017 Aug 16. doi: 10.1210/jc.2017-01113.
    PubMed     Text format     Abstract available


    February 2017
  32. TOULIS KA, Willis BH, Marshall T, Kumarendran B, et al
    All-cause mortality in patients with diabetes under treatment with dapagliflozin: a population-based, open-cohort study in THIN database.
    J Clin Endocrinol Metab. 2017 Feb 20. doi: 10.1210/jc.2016-3446.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: